GFR Assessment of Living Kidney Donors Candidates

被引:13
作者
Gaillard, Francois [1 ,2 ]
Legendre, Christophe [1 ,2 ]
White, Christine A. [3 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Renal Transplantat Dept, Paris, France
[2] Paris Descartes Univ, Paris, France
[3] Queens Univ, Dept Med, Kingston, ON, Canada
关键词
GLOMERULAR-FILTRATION-RATE; SHRUNKEN PORE SYNDROME; BETA-TRACE PROTEIN; SERUM CYSTATIN C; QUALITY-OF-LIFE; PLASMA-CLEARANCE; RENAL-FUNCTION; CREATININE; PERFORMANCE; EQUATIONS;
D O I
10.1097/TP.0000000000002620
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Living kidney donation provides the best outcomes (survival, cost, and quality of life) of all renal replacement modalities. Living kidney donors, on the other hand, are at the increased risk of end-stage kidney disease (ESKD) after donation compared with healthy nondonors for multiple possible reasons. Extensive predonation screening is required to assess eligibility for donation to avoid the rejection of suitable candidates and minimize acceptance of donors with increased risk of ESKD. The association between the lower predonation glomerular filtration rate (GFR) and increased ESKD risk in donors highlights the relevance of GFR assessment for living kidney donor candidates. However, the method to evaluate GFR is still debated, and the thresholds of acceptable predonation GFR vary across guidelines. All guidelines favor GFR measurement with an exogenous tracer over estimated GFR, but only the British Transplant Society guidelines mandates it. While the Kidney Disease Improving Global Outcomes Group guidelines advocates for age-independent GFR thresholds, most other guidelines propose various age-dependent GFR thresholds with resulting profound differences in assessment of donor suitability between guidelines. Many important questions are not addressed by any guidelines, including the approach to discordant GFR measurement and estimated GFR results, the use of method-specific GFR thresholds and thresholds dependent on comorbidities or race. Further data are required exploring the associations between these variables and the course of postdonation GFR. Last, GFR evaluation studies conducted in approved donors and not in those initially presenting as potential candidates are questionable regarding their suitability for potential donor evaluation.
引用
收藏
页码:1086 / 1093
页数:8
相关论文
共 74 条
  • [71] β-Trace Protein: A Marker of GFR and Other Biological Pathways
    White, Christine A.
    Ghazan-Shahi, Sassan
    Adams, Michael A.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (01) : 131 - 146
  • [72] Effect of Clinical Variables and Immunosuppression on Serum Cystatin C and Beta-Trace Protein in Kidney Transplant Recipients
    White, Christine A.
    Akbari, Ayub
    Doucette, Steve
    Fergusson, Dean
    Ramsay, Tim
    Hussain, Naser
    Dinh, Laurent
    Filler, Guido
    Lepage, Nathalie
    Knoll, Greg A.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (05) : 922 - 930
  • [73] Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
    Wolfe, RA
    Ashby, VB
    Milford, EL
    Ojo, AO
    Ettenger, RE
    Agodoa, LYC
    Held, PJ
    Port, FK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (23) : 1725 - 1730
  • [74] Measured (and estimated) glomerular filtration rate: reference values in West Africa
    Yayo, Eric
    Aye, Mireille
    Yao, Carine
    Gnionsahe, Appolinaire
    Attoungbre, Marie-Laure
    Cavalier, Etienne
    Pottel, Hans
    Monnet, Dagui
    Delanaye, Pierre
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (07) : 1176 - 1180